News und Analysen
Inogen Recognized as a Finalist for Ragan's CSR & Diversity Awards Program
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that it has been selected as a finalist in the
NanoString to Webcast Presentations from Upcoming Healthcare Conferences
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today announced that company management is scheduled to webcast
Inogen Announces Second Quarter 2023 Financial Results
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended June 30
Inogen Achieves Best In Class 8-Year Expected Service Life Portable Oxygen Concentrators
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced the introduction of the Rove 6™ portable oxygen
STAAR Surgical to Participate in Upcoming Investor Conferences
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that management will participate in several upcoming
Owens & Minor Reports Second Quarter 2023 Financial Results
Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the second quarter ended June 30, 2023.
Second Quarter Key Highlights:
-
Consolidated revenue of $2.56 billion
-
Net loss
H1 2023 result outperforms prior year at constant exchange rates
NanoString Technologies Releases Operating Results for Second Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported financial results for the second quarter ended June
STAAR Surgical Reports Second Quarter 2023 Results
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported financial results for the second quarter ended June 30, 2023
EQS-Adhoc: MeVis Medical Solutions AG: Adjusting forecast for the current fiscal year
EQS-News: MediClin AG: Higher demand for medical, therapeutic and nursing services led to an increase in sales and earnings in the Group
EQS-Adhoc: Eckert & Ziegler again achieves sales growth compared to the previous year and confirms its forecast for 2023. Decline in earnings compared to same period last year due to extraordinary items.
Owens & Minor Announces Second Quarter 2023 Earnings Release Date and Conference Call
Owens & Minor, Inc. (NYSE: OMI) plans to release financial results for the second quarter of 2023 on Friday, August 4, 2023, before trading begins on the New York Stock Exchange.
The Company
STAAR Surgical to Report Second Quarter Results on August 2, 2023
STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today announced that it will release financial results for the second
Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist
Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that the company has entered into a definitive
Simulations Plus Releases ADMET Predictor® 11
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation solutions for the pharmaceutical and biotechnology industries, today announced the release of ADMET Predictor®
Delaware District Court Permits NanoString’s Counterclaims that 10x Genomics and Harvard Violated the Antitrust Laws
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, provided comments on yesterday’s order of the United States District
NanoString Provides Preliminary Financial and Operational Highlights for Second Quarter of 2023
NanoString Technologies, Inc. (NASDAQ:NSTG), a leading provider of life science tools for discovery and translational research, today reported preliminary financial and operational highlights for
Simulations Plus Reports Third Quarter Fiscal 2023 Financial Results
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical drug discovery and development, today reported financial results for its
NanoString Reports Inducement Grants Under Nasdaq Listing Rules
NanoString Technologies, Inc. (Nasdaq: NSTG), a leading provider of life science tools for discovery and translational research, today announced, as required by Nasdaq Stock Market Rules, equity
Owens & Minor to Participate in UBS Healthcare Services Conference on Tuesday, June 27, 2023
Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed
MD Medical Group Investments Plc: MD Medical Group announces cancellation of listing on LSE
Simulations Plus Announces Third Quarter Fiscal Year 2023 Earnings and Conference Call Date
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), announced today that it will report third quarter fiscal 2023 financial results after the market close on Thursday, July 6, 2023.
Simulations Plus Acquires Immunetrics to Expand its Immunology and Oncology Drug Development Capabilities
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the
EQS-News: MediClin AG: MEDICLIN focusses on innovative outpatient concepts in rehabilitation